Pandemic Influenza Preparedness and Response

Provide development and acquisition of Medical Countermeasures (MCMs) for Pandemic Influenza Preparedness and Response. The following specific objectives highlight a comprehensive strategy and commitment by HHS to provide MCMs against pandemic influenza and influenza strains with pandemic potential: Master and working virus seed for production of influenza pre-pandemic and pandemic vaccine product; influenza pre-pandemic and pandemic vaccine production at pilot, clinical and commercial scale; adjuvant production at commercial scale; vaccine and adjuvant storage and stability programs; formulation, fill, finish of pre-pandemic, pandemic influenza vaccine and adjuvant; international and domestic shipping of vaccine, disposal of vaccine bulk and final container, non-clinical and clinical studies using pre-pandemic and pandemic influenza vaccine; storage services and stability program for vaccine and adjuvants, (bulk and final containers) from current contracts, when applicable.